Human t cell recognition of the blood stage antigen plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malaria

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Woodberry, Tonia ^a   Pinzon Charry, Alberto ^b   Piera, Kim A ^a   Panpisutchai, Yawalak ^b   Engwerda, Christian R ^b   Doolan, Denise L ^b   Salwati, Ervi ^c   Kenangalem, Enny ^d   Tjitra, Emiliana ^c   Price, Ric N ^a,e   Good, Michael F ^b   Anstey, Nicholas M ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^d National Institute of Health Research and Development Menzies   (Indonesia)

^e CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HYPOXANTHINE GUANINE XANTHINE PHOSPHORIBOSYL TRANSFERASE; IMMUNOGLOBULIN G; PHOSPHORIBOSYLTRANSFERASE; UNCLASSIFIED DRUG; GLYCOSYLTRANSFERASE; HYPOXANTHINE GUANINE XANTHINE PHOSPHORIBOSYLTRANSFERASE; HYPOXANTHINE-GUANINE-XANTHINE PHOSPHORIBOSYLTRANSFERASE; PROTOZOAL PROTEIN;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; INDONESIA; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM; SCHOOL CHILD; SEQUENCE ANALYSIS; T LYMPHOCYTE; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; IMMUNOLOGY; MALARIA FALCIPARUM; MIDDLE AGED; MOLECULAR GENETICS; MONONUCLEAR CELL; MOUSE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; SECRETION; SEQUENCE ALIGNMENT; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MALARIA, FALCIPARUM; MALE; MICE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PENTOSYLTRANSFERASES; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SEQUENCE ALIGNMENT; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 67949112688     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-122     Document Type: Article

References (43)

1. The global distribution of clinical episodes of Plasmodium falciparum malaria. RW Snow CA Guerra AM Noor HY Myint SI Hay, Nature 2005 434 214 217 10.1038/nature03342 15759000 (Pubitemid 40388051)
2. Immunization of man against sporozite-induced falciparum malaria. DF Clyde H Most VC McCarthy JP Vanderberg, Am J Med Sci 1973 266 169 177 10.1097/00000441-197309000-00002 4583408
3. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. SL Hoffman LM Goh TC Luke I Schneider TP Le DL Doolan J Sacci P de la Vega M Dowler C Paul, J Infect Dis 2002 185 1155 1164 10.1086/339409 11930326 (Pubitemid 34297774)
4. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. DJ Pombo G Lawrence C Hirunpetcharat C Rzepczyk M Bryden N Cloonan K Anderson Y Mahakunkijcharoen LB Martin D Wilson, Lancet 2002 360 610 617 10.1016/S0140-6736(02)09784-2 12241933 (Pubitemid 35232195)
5. Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration. MD Edstein BM Kotecka KL Anderson DJ Pombo DE Kyle KH Rieckmann MF Good, Antimicrob Agents Chemother 2005 49 4421 4422 16189139 10.1128/AAC.49.10.4421-4422.2005 (Pubitemid 41401005)
6. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. P Bejon J Lusingu A Olotu A Leach M Lievens J Vekemans S Mshamu T Lang J Gould MC Dubois, N Engl J Med 2008 359 2521 2532 19064627 10.1056/NEJMoa0807381
7. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. S Abdulla R Oberholzer O Juma S Kubhoja F Machera C Membi S Omari A Urassa H Mshinda A Jumanne, N Engl J Med 2008 359 2533 2544 10.1056/NEJMoa0807773 19064623
8. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. PL Alonso J Sacarlal JJ Aponte A Leach E Macete P Aide B Sigauque J Milman I Mandomando Q Bassat, Lancet 2005 366 2012 2018 10.1016/S0140-6736(05)67669-6 16338450 (Pubitemid 41773376)
9. A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge. SJ Dunachie M Walther JE Epstein S Keating T Berthoud L Andrews RF Andersen P Bejon N Goonetilleke I Poulton, Infect Immun 2006 74 5933 5942 16988273 10.1128/IAI.00590-06 (Pubitemid 44484581)
10. Rationale for the development of an engineered sporozoite malaria vaccine. V Nussenzweig RS Nussenzweig, Adv Immunol 1989 45 283 334 10.1016/S0065-2776(08)60695-1 2665440
11. Immune response to pre-erythrocytic stages of malaria parasites. DL Doolan N Martinez-Alier, Curr Mol Med 2006 6 169 185 10.2174/156652406776055249 16515509
12. Immunity to Plasmodium chabaudi adami in the B-cell-deficient mouse. JL Grun WP Weidanz, Nature 1981 290 5802 143 145 10.1038/290143a0 6970898 (Pubitemid 11149689)
13. Resolution of acute malarial infections by T cell-dependent non-antibody-mediated mechanisms of immunity. LA Cavacini LA Parke WP Weidanz, Infect Immun 1990 58 2946 2950 2387628
14. Plasmodium berghei: T cell dependence of sporozoite-induced immunity in rodents. GL Spitalny JP Verhave JH Meuwissen RS Nussenzweig, Exp Parasitol 1977 42 73 81 10.1016/0014-4894(77)90063-7 324789
15. Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. JE Egan JL Weber WR Ballou MR Hollingdale WR Majarian DM Gordon WL Maloy SL Hoffman RA Wirtz I Schneider, Science 1987 236 453 456 10.1126/science.3551073 3551073
16. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. WR Weiss M Sedegah RL Beaudoin LH Miller MF Good, Proc Natl Acad Sci USA 1988 85 573 576 2963334 10.1073/pnas.85.2.573
17. CD4+ cytolytic T cell clone confers protection against murine malaria. M Tsuji P Romero RS Nussenzweig F Zavala, J Exp Med 1990 172 1353 1357 2146361 10.1084/jem.172.5.1353
18. The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malaria. MO Makobongo G Riding H Xu C Hirunpetcharat D Keough J de Jersey P Willadsen MF Good, Proc Natl Acad Sci USA 2003 100 2628 2633 12594331 10.1073/pnas.0337629100 (Pubitemid 36297549)
19. Localisation of hypoxanthine phosphoribosyl transferase in the malaria parasite Plasmodium falciparum. M Shahabuddin K Gunther K Lingelbach M Aikawa M Schreiber RG Ridley JG Scaife, Exp Parasitol 1992 74 11 19 10.1016/0014-4894(92) 90134-V 1730267
20. Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum. P Reyes PK Rathod DJ Sanchez JE Mrema KH Rieckmann HG Heidrich, Mol Biochem Parasitol 1982 5 275 290 10.1016/0166- 6851(82)90035-4 6285190
21. Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. M Karyana L Burdarm S Yeung E Kenangalem N Wariker R Maristela KG Umana R Vemuri MJ Okoseray PM Penttinen, Malar J 2008 7 148 18673572 10.1186/1475-2875-7-148
22. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. A Ratcliff H Siswantoro E Kenangalem R Maristela RM Wuwung F Laihad EP Ebsworth NM Anstey E Tjitra RN Price, Lancet 2007 369 757 765 17336652 10.1016/S0140- 6736(07)60160-3 (Pubitemid 46335820)
23. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. A Ratcliff H Siswantoro E Kenangalem M Wuwung A Brockman MD Edstein F Laihad EP Ebsworth NM Anstey E Tjitra, Trans R Soc Trop Med Hyg 2007 101 351 359 17028048 10.1016/j.trstmh.2006.06.008 (Pubitemid 46205894)
24. PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. A Bahl B Brunk J Crabtree MJ Fraunholz B Gajria GR Grant H Ginsburg D Gupta JC Kissinger P Labo, Nucleic Acids Res 2003 31 1 212 215 12519984 10.1093/nar/gkg081 (Pubitemid 36150367)
25. Purification and characterization of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase and comparison with the human enzyme. DT Keough AL Ng DJ Winzor BT Emmerson J de Jersey, Mol Biochem Parasitol 1999 98 1 29 41 10.1016/S0166-6851(98)00139-X 10029307 (Pubitemid 29027927)
26. Characterisation of cDNA clones for hypoxanthine-guanine phosphoribosyltransferase from the human malarial parasite, Plasmodium falciparum: comparisons to the mammalian gene and protein. A King DW Melton, Nucleic Acids Res 1987 15 24 10469 10481 3320967 10.1093/nar/15.24.10469
27. Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses. T Woodberry G Minigo KA Piera JC Hanley HD de Silva E Salwati E Kenangalem E Tjitra RL Coppel RN Price, J Infect Dis 2008 198 1 134 142 10.1086/588711 18471084 (Pubitemid 351920300)
28. Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays. KL Flanagan EA Lee MB Gravenor WH Reece BC Urban T Doherty KA Bojang M Pinder AV Hill M Plebanski, J Immunol 2001 167 8 4729 4737 11591804
29. Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. G Minigo T Woodberry KA Piera E Salwati E Tjitra E Kenangalem RN Price CR Engwerda NM Anstey M Plebanski, PLoS Pathog 2009 5 4 e1000402 19390618 10.1371/journal.ppat. 1000402
30. Cytokines in the pathogenesis of and protection against malaria. I Angulo M Fresno, Clin Diagn Lab Immunol 2002 9 6 1145 1152 12414742
31. Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. R Wang J Epstein FM Baraceros EJ Gorak Y Charoenvit DJ Carucci RC Hedstrom N Rahardjo T Gay P Hobart, Proc Natl Acad Sci USA 2001 98 19 10817 10822 11526203 10.1073/pnas.181123498 (Pubitemid 32878703)
32. Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein. R Wang J Epstein Y Charoenvit FM Baraceros N Rahardjo T Gay JG Banania R Chattopadhyay P de la Vega TL Richie, J Immunol 2004 172 9 5561 5569 15100299 (Pubitemid 38542058)
33. Regulation of the immune response in Plasmodium falciparum malaria. III. Proliferative response to antigen in vitro and subset composition of T cells from patients with acute infection or from immune donors. M Troye-Blomberg P Romero ME Patarroyo A Bjorkman P Perlmann, Clin Exp Immunol 1984 58 2 380 387 6209042
34. Cellular and antibody responses to the Plasmodium falciparum heat shock protein Pf72/HSP70 during and after acute malaria in individuals from an endemic area of Brazil. J de Oliveira-Ferreira DM Banic F Santos MF Ferreira-da-Cruz P Dubois CT Daniel-Ribeiro, Acta Trop 1999 73 1 10 10.1016/S0001-706X(99)00008-X 10379811 (Pubitemid 29238106)
35. Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. M Ho HK Webster S Looareesuwan W Supanaranond RE Phillips P Chanthavanich DA Warrell, J Infect Dis 1986 153 763 771 2936834
36. Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria. EM Riley G Andersson LN Otoo S Jepsen BM Greenwood, Clin Exp Immunol 1988 73 17 22 3139343
37. Suppression of parasite-specific response in Plasmodium falciparum malaria. A longitudinal study of blood mononuclear cell proliferation and subset composition. TG Theander IC Bygbjerg BJ Andersen S Jepsen A Kharazmi N Odum, Scand J Immunol 1986 24 73 81 10.1111/j.1365-3083.1986.tb02071.x 2425416
38. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. A Joss M Akdis A Faith K Blaser CA Akdis, Eur J Immunol 2000 30 1683 1690 10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0. CO;2-A 10898505
39. The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infection. H Xu J Wipasa H Yan M Zeng MO Makobongo FD Finkelman A Kelso MF Good, J Exp Med 2002 195 881 892 11927632 10.1084/jem.20011174 (Pubitemid 34286759)
40. The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. P Bejon J Mwacharo O Kai S Todryk S Keating B Lowe T Lang TW Mwangi SC Gilbert N Peshu, J Immunol 2007 179 4193 4201 17785859
41. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. MF Good D Pombo IA Quakyi EM Riley RA Houghten A Menon DW Alling JA Berzofsky LH Miller, Proc Natl Acad Sci USA 1988 85 1199 1203 2448793 10.1073/pnas.85.4.1199
42. T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic. M Connelly CL King K Bucci S Walters B Genton MP Alpers M Hollingdale JW Kazura, Infect Immun 1997 65 5082 5087 9393799
43. Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India. SK Joshi A Bharadwaj S Chatterjee VS Chauhan, Infect Immun 2000 68 141 150 10603380 10.1128/IAI.68.1.141-150.2000